Cellestis Ltd's QuantiFeron-TB
This article was originally published in The Gray Sheet
Executive Summary
Whole blood assay intended as an aid in diagnosis of tuberculosis and evaluation of those suspected of having Mycobacterium tuberculosis infection gains unanimous (6-0) approval recommendation from FDA's Microbiology Devices Panel at an Oct. 12 meeting in Gaithersburg, Maryland